Global Organ Preservation Technology Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Organ Preservation Technology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Organ preservation technology refers to the methods and techniques used to maintain the viability and function of organs for transplantation or research purposes. The primary goal of organ preservation is to extend the time between the removal of an organ from a donor and its transplantation into a recipient, allowing for better organ matching and reducing the risk of organ damage.

The global organ preservation technology market has been experiencing growth due to the increasing demand for organ transplantation, advancements in preservation techniques, and the growing prevalence of chronic diseases leading to organ failure. Organ preservation technology plays a crucial role in maintaining the viability of organs for transplantation, reducing the risk of organ damage, and improving the success rates of organ transplantation procedures. North America and Europe have been the largest markets for organ preservation technology, driven by well-established healthcare infrastructure, a higher number of organ transplant procedures, and significant investments in research and development. Asia-Pacific has also witnessed substantial growth due to increasing awareness of organ transplantation, improving healthcare facilities, and rising demand for transplantation.

This report is a detailed and comprehensive analysis for global Organ Preservation Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Organ Preservation Technology market size and forecasts, in consumption value ($ Million), 2020-2031

Global Organ Preservation Technology market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Organ Preservation Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Organ Preservation Technology market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Organ Preservation Technology

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Organ Preservation Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioLife Solutions, Dr. Franz Köhler Chemie GmbH, 21st Century Medicine, Bridge to Life, Teva Pharmaceuticals, Lifeline Scientific, XVIVO Perfusion, Artivion, Preservation Solutions, Bristol Myers Squibb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Organ Preservation Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others

Market segment by Application
Kidney
Liver
Heart
Lung
Others

Market segment by players, this report covers
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
21st Century Medicine
Bridge to Life
Teva Pharmaceuticals
Lifeline Scientific
XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Accord Healthcare
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Paragonix Technologies
Waters Medical Systems
OrganOx

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Organ Preservation Technology product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Organ Preservation Technology, with revenue, gross margin, and global market share of Organ Preservation Technology from 2020 to 2025.

Chapter 3, the Organ Preservation Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Organ Preservation Technology market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Organ Preservation Technology.

Chapter 13, to describe Organ Preservation Technology research findings and conclusion.